NASDAQ:ENTL - Entellus Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$24.00 0.00 (0.00 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$24.00
Today's Range$24.00 - $24.00
52-Week Range$11.47 - $25.58
VolumeN/A
Average Volume178,331 shs
Market Capitalization$611.38 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.02

About Entellus Medical (NASDAQ:ENTL)

Entellus Medical logoEntellus Medical, Inc. is a medical technology company. The Company is focused on delivering patient and physician experiences through products designed for the minimally invasive treatment of chronic and recurrent sinusitis in both adult and pediatric patients. Its three core product lines, XprESS Multi-Sinus Dilation Systems, MiniFESS Surgical Instruments, and FocESS Imaging & Navigation, are designed to enable ear, nose and throat (ENT), physicians to perform a range of procedures in the ENT physician office and to simplify operating room-based treatment. The Company's XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The MiniFESS family of surgical instruments includes eight devices designed to enable physicians to perform various surgical procedures. The Fiagon Image Guidance System (IGS) consists of a navigation unit, navigation sensor, software instruments and a patient localizer.

Receive ENTL News and Ratings via Email

Sign-up to receive the latest news and ratings for ENTL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:ENTL
CUSIPN/A
Phone+1-763-4631595

Debt

Debt-to-Equity Ratio0.32
Current Ratio1.92
Quick Ratio1.71

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$75.18 million
Price / Sales8.21
Cash FlowN/A
Price / CashN/A
Book Value$1.87 per share
Price / Book12.83

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-28,710,000.00
Net Margins-31.24%
Return on Equity-47.37%
Return on Assets-27.29%

Miscellaneous

Employees280
Outstanding Shares25,730,000

Entellus Medical (NASDAQ:ENTL) Frequently Asked Questions

What is Entellus Medical's stock symbol?

Entellus Medical trades on the NASDAQ under the ticker symbol "ENTL."

How were Entellus Medical's earnings last quarter?

Entellus Medical Inc (NASDAQ:ENTL) announced its earnings results on Thursday, November, 3rd. The medical technology company reported ($0.50) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.37) by $0.13. The medical technology company earned $17.90 million during the quarter, compared to analysts' expectations of $17.93 million. Entellus Medical had a negative net margin of 31.24% and a negative return on equity of 47.37%. The firm's revenue for the quarter was up 20.9% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.32) EPS. View Entellus Medical's Earnings History.

What price target have analysts set for ENTL?

3 equities research analysts have issued 12 month target prices for Entellus Medical's stock. Their forecasts range from $17.00 to $21.00. On average, they anticipate Entellus Medical's share price to reach $19.00 in the next twelve months. View Analyst Ratings for Entellus Medical.

Who are Entellus Medical's key executives?

Entellus Medical's management team includes the folowing people:
  • Robert S. White, President, Chief Executive Officer, Director
  • Brent A. Moen, Chief Financial Officer, Corporate Secretary
  • Michael H. Rosenthal, Chief Operating Officer
  • Jonelle R. Burnham, Chief Compliance Officer, Vice President, General Counsel
  • Stephen R. Paidosh, Vice President, Operations
  • Thomas D. Williamson, Vice President - Sales
  • Kevin L. Mensink, Vice President of Marketing
  • Martha J. Christian, Vice President, Reimbursement
  • Timothy B. Petrick, Vice President, Research and Development
  • Brian E. Farley, Non-Executive Chairman of the Board

When did Entellus Medical IPO?

(ENTL) raised $70 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,400,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch and Piper Jaffray served as the underwriters for the IPO and William Blair and Canaccord Genuity were co-managers.

Has Entellus Medical been receiving favorable news coverage?

News headlines about ENTL stock have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Entellus Medical earned a coverage optimism score of 0.12 on Accern's scale. They also assigned news coverage about the medical technology company an impact score of 46.66 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Entellus Medical's major shareholders?

Entellus Medical's stock is owned by a number of of retail and institutional investors. Top institutional investors include STRYKER CORP (100.00%) and STRYKER CORP (100.00%). Company insiders that own Entellus Medical stock include Brent Moen, Brian E Farley, James D Surek, Joshua J Baltzell, Karen E Peterson, Kevin L Mensink, Life Sciences Fu International, Margaret A Boiano, Robert S White, Stephen R Paidosh, Thomas P Williamson and Timothy B Petrick. View Institutional Ownership Trends for Entellus Medical.

How do I buy shares of Entellus Medical?

Shares of ENTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Entellus Medical's stock price today?

One share of ENTL stock can currently be purchased for approximately $24.00.

How big of a company is Entellus Medical?

Entellus Medical has a market capitalization of $611.38 million and generates $75.18 million in revenue each year. Entellus Medical employs 280 workers across the globe.

How can I contact Entellus Medical?

Entellus Medical's mailing address is 3600 Holly Ln N Ste 40, PLYMOUTH, MN 55447-1286, United States. The medical technology company can be reached via phone at +1-763-4631595.


MarketBeat Community Rating for Entellus Medical (ENTL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  174 (Vote Outperform)
Underperform Votes:  133 (Vote Underperform)
Total Votes:  307
MarketBeat's community ratings are surveys of what our community members think about Entellus Medical and other stocks. Vote "Outperform" if you believe ENTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ENTL will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Entellus Medical (NASDAQ:ENTL) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Entellus Medical in the last 12 months. Their average twelve-month price target is $19.00, suggesting that the stock has a possible downside of 20.83%. The high price target for ENTL is $21.00 and the low price target for ENTL is $17.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.33
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $19.00$19.00$19.00$20.80
Price Target Upside: 20.83% downside20.80% downside20.80% downside10.82% upside

Entellus Medical (NASDAQ:ENTL) Consensus Price Target History

Price Target History for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ:ENTL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/8/2017William BlairDowngradeOutperform ➝ Market PerformMediumView Rating Details
10/17/2017Canaccord GenuityReiterated RatingHold$17.00N/AView Rating Details
8/22/2017Piper Jaffray CompaniesReiterated RatingBuy$21.00LowView Rating Details
2/22/2017Bank of AmericaDowngradeBuy ➝ Underperform$16.00N/AView Rating Details
2/22/2017BTIG ResearchDowngradeBuy ➝ NeutralN/AView Rating Details
12/6/2016GuggenheimInitiated CoverageBuy$25.00N/AView Rating Details
11/4/2016Deutsche BankReiterated RatingBuy$25.00 ➝ $26.00N/AView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Entellus Medical (NASDAQ:ENTL) Earnings History and Estimates Chart

Earnings by Quarter for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ:ENTL) Earnings Estimates

2018 EPS Consensus Estimate: ($1.15)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.34)($0.34)($0.34)
Q2 20181($0.27)($0.27)($0.27)
Q3 20181($0.30)($0.30)($0.30)
Q4 20181($0.24)($0.24)($0.24)

Entellus Medical (NASDAQ ENTL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017Q3 2017($0.51)($0.49)$22.97 million$23.33 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.34)($0.37)$21.87 million$22.10 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.44)($0.40)$19.61 million$19.11 millionViewListenView Earnings Details
2/21/2017Q4 2016($0.3340)($0.39)$21.58 million$21.70 millionViewListenView Earnings Details
11/3/2016Q3($0.37)($0.50)$17.93 million$17.90 millionViewListenView Earnings Details
8/3/2016Q2($0.35)($0.27)$18.48 million$18.73 millionViewListenView Earnings Details
5/4/2016Q1($0.47)($0.37)$16.34 million$16.90 millionViewListenView Earnings Details
2/24/2016Q4($0.26)($0.27)$17.52 million$18.07 millionViewListenView Earnings Details
11/5/2015Q315($0.25)($0.32)$14.19 million$14.80 millionViewListenView Earnings Details
8/6/2015Q215($0.20)($0.15)$15.00 million$15.20 millionViewListenView Earnings Details
5/7/2015Q1 2015($0.48)($0.35)$13.02 million$13.50 millionViewN/AView Earnings Details
3/17/2015Q4 2014($0.73)$14.46 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Entellus Medical (NASDAQ:ENTL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Entellus Medical (NASDAQ ENTL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.70%
Institutional Ownership Percentage: 83.44%
Insider Trading History for Entellus Medical (NASDAQ:ENTL)
Insider Trading History for Entellus Medical (NASDAQ:ENTL)

Entellus Medical (NASDAQ ENTL) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/8/2018Thomas P. WilliamsonVPSell2,449$24.08$58,971.92View SEC Filing  
1/5/2018Brent MoenCFOSell735$24.01$17,647.35View SEC Filing  
1/5/2018Robert S. WhiteInsiderSell3,471$24.01$83,338.71View SEC Filing  
1/5/2018Thomas P. WilliamsonVPSell968$24.01$23,241.68View SEC Filing  
12/7/2017Brian E. FarleyDirectorSell101,319$23.85$2,416,458.15View SEC Filing  
10/20/2017Kevin L. MensinkVPSell2,500$19.00$47,500.00View SEC Filing  
10/16/2017Kevin L. MensinkVPSell10,000$18.29$182,900.00View SEC Filing  
10/9/2017Karen E PetersonVPSell650$20.17$13,110.50View SEC Filing  
10/4/2017Brian E FarleyDirectorSell40,000$19.78$791,200.00View SEC Filing  
10/4/2017Timothy B PetrickVPSell2,000$20.01$40,020.00View SEC Filing  
10/3/2017Brian E. FarleyDirectorSell6,028$19.17$115,556.76View SEC Filing  
10/2/2017Brian E. FarleyDirectorSell3,972$19.10$75,865.20View SEC Filing  
9/22/2017Timothy B. PetrickVPSell2,000$18.00$36,000.00View SEC Filing  
9/13/2017Stephen R. PaidoshVPSell25,000$17.54$438,500.00View SEC Filing  
5/8/2017Brent MoenCFOBuy6,100$12.21$74,481.00View SEC Filing  
5/8/2017Joshua J BaltzellDirectorBuy1,600$12.34$19,744.002,850View SEC Filing  
5/8/2017Robert S. WhiteInsiderBuy10,000$12.24$122,400.00View SEC Filing  
1/31/2017Life Sciences Fu InternationalMajor ShareholderSell533,077$17.00$9,062,309.00View SEC Filing  
1/13/2017Brian E FarleyDirectorSell14,019$20.14$282,342.66430,562View SEC Filing  
1/13/2017Karen E. PetersonVPSell10,000$20.13$201,300.00View SEC Filing  
1/10/2017Brian E FarleyDirectorSell9,842$19.11$188,080.62449,423View SEC Filing  
1/10/2017Karen E. PetersonVPSell9,840$19.11$188,042.40View SEC Filing  
1/4/2017Brian E FarleyDirectorSell20,158$18.74$377,760.92454,581View SEC Filing  
1/4/2017Karen E PetersonVPSell10,160$18.74$190,398.4043,384View SEC Filing  
12/6/2016Brian E FarleyDirectorSell15,000$18.57$278,550.00484,581View SEC Filing  
11/23/2016Brian E FarleyDirectorSell5,000$19.00$95,000.00494,581View SEC Filing  
11/18/2016Brian E FarleyDirectorSell10,000$18.30$183,000.00509,581View SEC Filing  
10/13/2016Margaret A. BoianoVPSell11,103$20.01$222,171.03View SEC Filing  
10/5/2016Brian E FarleyDirectorSell30,000$22.26$667,800.00514,581View SEC Filing  
9/8/2016James D SurekVPSell10,000$18.71$187,100.0095,031View SEC Filing  
9/2/2016Brian E FarleyDirectorSell11,078$18.62$206,272.36544,581View SEC Filing  
9/1/2016Brian E FarleyDirectorSell17,006$19.33$328,725.98560,265View SEC Filing  
9/1/2016Kevin L. MensinkVPSell8,000$18.39$147,120.00View SEC Filing  
8/1/2016Kevin L MensinkVPSell8,100$17.63$142,803.008,000View SEC Filing  
7/18/2016Timothy B. PetrickVPSell3,000$18.15$54,450.00View SEC Filing  
2/11/2016Karen E PetersonInsiderSell5,000$16.00$80,000.0058,384View SEC Filing  
2/4/2016Karen E PetersonInsiderSell10,000$17.00$170,000.0063,384View SEC Filing  
9/17/2015Brian E. FarleyChairmanSell5,484$22.00$120,648.00572,665View SEC Filing  
9/15/2015Brian E. FarleyChairmanSell27,619$22.18$612,589.42578,149View SEC Filing  
9/14/2015Brian E. FarleyChairmanSell21,187$22.15$469,292.05578,149View SEC Filing  
9/2/2015James D SurekVPSell15,000$21.27$319,050.00105,031View SEC Filing  
8/31/2015James D. SurekVPSell5,000$22.29$111,450.00120,031View SEC Filing  
2/3/2015Robert S WhiteCOOBuy5,882$17.00$99,994.00View SEC Filing  
2/3/2015Shawn MccormickDirectorBuy2,941$17.00$49,997.00View SEC Filing  
2/3/2015Woodlands Health Venture EssexMajor ShareholderBuy352,941$17.00$5,999,997.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Entellus Medical (NASDAQ ENTL) News Headlines

Source:
DateHeadline
Entellus Medical Inc (ENTL) Given Average Recommendation of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 22 at 5:34 AM
BidaskClub Downgrades Entellus Medical (ENTL) to BuyBidaskClub Downgrades Entellus Medical (ENTL) to Buy
www.americanbankingnews.com - April 16 at 10:25 AM
Entellus Medical (ENTL) Rating Lowered to Hold at BidaskClubEntellus Medical (ENTL) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 14 at 5:51 PM
Entellus Medical (ENTL) Downgraded by Zacks Investment ResearchEntellus Medical (ENTL) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 8 at 10:27 AM
Entellus Medical (ENTL) Rating Lowered to Sell at Zacks Investment ResearchEntellus Medical (ENTL) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 31 at 12:32 PM
Entellus Medical (ENTL) Lifted to Hold at Zacks Investment ResearchEntellus Medical (ENTL) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - March 28 at 12:58 PM
Entellus Medical Inc (ENTL) Receives Average Recommendation of "Hold" from AnalystsEntellus Medical Inc (ENTL) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 28 at 5:43 AM
Entellus Medical (ENTL) Rating Lowered to Strong Sell at BidaskClubEntellus Medical (ENTL) Rating Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - March 28 at 12:34 AM
Entellus Medical (ENTL) Rating Increased to Sell at BidaskClubEntellus Medical (ENTL) Rating Increased to Sell at BidaskClub
www.americanbankingnews.com - March 25 at 3:12 PM
Entellus Medical Inc (ENTL) Receives Consensus Recommendation of "Hold" from BrokeragesEntellus Medical Inc (ENTL) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 3 at 5:34 AM
Water Island Capital LLC Invests $4.81 Million in Entellus Medical Inc (ENTL) StockWater Island Capital LLC Invests $4.81 Million in Entellus Medical Inc (ENTL) Stock
www.americanbankingnews.com - March 2 at 9:50 PM
Sand Grove Capital Management LLP Purchases New Holdings in Entellus Medical Inc (ENTL)Sand Grove Capital Management LLP Purchases New Holdings in Entellus Medical Inc (ENTL)
www.americanbankingnews.com - March 1 at 4:44 PM
Entellus Medical (ENTL) to Release Earnings on MondayEntellus Medical (ENTL) to Release Earnings on Monday
www.americanbankingnews.com - February 12 at 3:02 AM
New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Atara Biotherapeutics, SPX, Entellus Medical, Columbus McKinnon, NantKwest, and Merrimack Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - February 6 at 9:07 AM
Entellus Medical Inc (ENTL) Given Consensus Rating of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 6 at 5:10 AM
-$0.44 EPS Expected for Entellus Medical Inc (ENTL) This Quarter-$0.44 EPS Expected for Entellus Medical Inc (ENTL) This Quarter
www.americanbankingnews.com - February 4 at 3:16 AM
Entellus Medical (ENTL) Stock Rating Lowered by Zacks Investment ResearchEntellus Medical (ENTL) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - January 24 at 10:50 PM
$28.75 Million in Sales Expected for Entellus Medical Inc (ENTL) This Quarter$28.75 Million in Sales Expected for Entellus Medical Inc (ENTL) This Quarter
www.americanbankingnews.com - January 20 at 2:04 PM
The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation ...The Law Offices of Vincent Wong Notifies Investors of a Complaint on Behalf of Entellus Medical, Inc. Shareholders Concerning the Sale of the Company to Stryker Corporation ...
www.businesswire.com - January 18 at 10:57 AM
Entellus Medical Inc (ENTL) Expected to Announce Earnings of -$0.45 Per ShareEntellus Medical Inc (ENTL) Expected to Announce Earnings of -$0.45 Per Share
www.americanbankingnews.com - January 18 at 5:06 AM
Entellus Medical Inc (ENTL) Sees Large Decline in Short InterestEntellus Medical Inc (ENTL) Sees Large Decline in Short Interest
www.americanbankingnews.com - January 15 at 4:40 AM
Entellus Medical Inc (ENTL) CFO Brent Moen Sells 735 SharesEntellus Medical Inc (ENTL) CFO Brent Moen Sells 735 Shares
www.americanbankingnews.com - January 9 at 7:56 PM
Entellus Medical Inc (ENTL) VP Sells $23,241.68 in StockEntellus Medical Inc (ENTL) VP Sells $23,241.68 in Stock
www.americanbankingnews.com - January 9 at 7:56 PM
Robert S. White Sells 3,471 Shares of Entellus Medical Inc (ENTL) StockRobert S. White Sells 3,471 Shares of Entellus Medical Inc (ENTL) Stock
www.americanbankingnews.com - January 9 at 7:16 PM
Entellus Medical Inc (ENTL) VP Thomas P. Williamson Sells 2,449 SharesEntellus Medical Inc (ENTL) VP Thomas P. Williamson Sells 2,449 Shares
www.americanbankingnews.com - January 9 at 7:16 PM
ACT NOW: Monteverde & Associates PC Announces An Investigation Of Entellus Medical, Inc. - ENTLACT NOW: Monteverde & Associates PC Announces An Investigation Of Entellus Medical, Inc. - ENTL
finance.yahoo.com - January 8 at 4:59 PM
Entellus (ENTL) Nears 52-Week High: Whats Driving It?Entellus (ENTL) Nears 52-Week High: What's Driving It?
www.zacks.com - January 3 at 4:55 PM
 Brokerages Expect Entellus Medical Inc (ENTL) Will Post Quarterly Sales of $28.75 Million Brokerages Expect Entellus Medical Inc (ENTL) Will Post Quarterly Sales of $28.75 Million
www.americanbankingnews.com - January 3 at 8:30 AM
Zacks: Brokerages Anticipate Entellus Medical Inc (ENTL) to Post -$0.45 EPSZacks: Brokerages Anticipate Entellus Medical Inc (ENTL) to Post -$0.45 EPS
www.americanbankingnews.com - January 1 at 11:22 AM
Entellus Medical Inc (ENTL) Sees Large Decrease in Short InterestEntellus Medical Inc (ENTL) Sees Large Decrease in Short Interest
www.americanbankingnews.com - December 31 at 3:14 AM
Lifshitz & Miller LLP Announces Investigation of Atlantic Coast Financial Corporation, Bazaarvoice, Inc., Buffalo Wild Wings, Inc., Entellus Medical, Inc., General Cable Corporation, Quality Systems, Inc., and Shopify Inc.Lifshitz & Miller LLP Announces Investigation of Atlantic Coast Financial Corporation, Bazaarvoice, Inc., Buffalo Wild Wings, Inc., Entellus Medical, Inc., General Cable Corporation, Quality Systems, Inc., and Shopify Inc.
finance.yahoo.com - December 28 at 3:36 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTLINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders - ENTL
finance.yahoo.com - December 28 at 12:12 PM
Entellus Medical Inc (ENTL) Given Consensus Recommendation of "Hold" by BrokeragesEntellus Medical Inc (ENTL) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 18 at 8:44 AM
Entellus Medical (ENTL) Rating Increased to C- at TheStreetEntellus Medical (ENTL) Rating Increased to C- at TheStreet
www.americanbankingnews.com - December 16 at 9:36 AM
 Brokerages Anticipate Entellus Medical Inc (ENTL) Will Post Earnings of -$0.45 Per Share Brokerages Anticipate Entellus Medical Inc (ENTL) Will Post Earnings of -$0.45 Per Share
www.americanbankingnews.com - December 15 at 7:08 PM
The Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker CorporationThe Law Offices of Vincent Wong Notifies Investors of an Investigation of Entellus Medical, Inc. Concerning the Sale of the Company to Stryker Corporation
finance.yahoo.com - December 13 at 5:02 PM
Entellus Medical (ENTL) Upgraded to Hold by ValuEngineEntellus Medical (ENTL) Upgraded to Hold by ValuEngine
www.americanbankingnews.com - December 9 at 5:08 PM
Entellus Medical IncEntellus Medical Inc
www.bloomberg.com - December 9 at 4:48 PM
Entellus Medical (ENTL) to be Acquired by Stryker (SYK) for $24 Per Share in CashEntellus Medical (ENTL) to be Acquired by Stryker (SYK) for $24 Per Share in Cash
www.streetinsider.com - December 9 at 4:48 PM
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to ShareholdersINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders
finance.yahoo.com - December 8 at 4:48 PM
Entellus Medical (ENTL) Cut to Hold at William BlairEntellus Medical (ENTL) Cut to Hold at William Blair
www.americanbankingnews.com - December 8 at 2:34 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTLSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per Share is Fair to Shareholders – ENTL
finance.yahoo.com - December 8 at 9:59 AM
ETFs with exposure to Entellus Medical, Inc. : December 7, 2017ETFs with exposure to Entellus Medical, Inc. : December 7, 2017
finance.yahoo.com - December 8 at 9:59 AM
Is There Now An Opportunity In Entellus Medical Inc (ENTL)?Is There Now An Opportunity In Entellus Medical Inc (ENTL)?
finance.yahoo.com - December 8 at 9:59 AM
Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017Entellus Medical, Inc. breached its 50 day moving average in a Bullish Manner : ENTL-US : December 8, 2017
finance.yahoo.com - December 8 at 9:59 AM
Brian E. Farley Sells 101,319 Shares of Entellus Medical Inc (ENTL) StockBrian E. Farley Sells 101,319 Shares of Entellus Medical Inc (ENTL) Stock
www.americanbankingnews.com - December 7 at 5:26 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per ...SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Entellus Medical, Inc. to Stryker Corporation for $24.00 Per ...
www.businesswire.com - December 7 at 5:13 PM
Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in CashEntellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Share in Cash
finance.yahoo.com - December 7 at 10:20 AM
Stryker announces definitive agreement to acquire EntellusStryker announces definitive agreement to acquire Entellus
finance.yahoo.com - December 7 at 10:20 AM
Entellus Medical to be acquired by Stryker for $24 a share in cashEntellus Medical to be acquired by Stryker for $24 a share in cash
finance.yahoo.com - December 7 at 10:20 AM

SEC Filings

Entellus Medical (NASDAQ:ENTL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Entellus Medical (NASDAQ:ENTL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Entellus Medical (NASDAQ ENTL) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.